SKCM patients with advanced tumor state (pathologic T stage 3–4, Clark level IV-V, and Breslow depth >3 mm) tended to express more abundant SCARB1 significantly (all p < 0.05, Figure 8G–8I). This evidence concerns the gene SCARB1 and neoplasm.